Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2006-12-31
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis:
The fifth reference percentile of the phase angle norm values is a prognostically relevant cut off value indicating cancer cachexia in terms of malnutrition, fatigue and impaired functional status, as well as predictive of 6-month mortality
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Cachexia in Patients Undergoing Chemotherapy
NCT01939340
Nutritional Status Assessment in the Elderly Suffering From Cancer : a National Cross-UCOG Survey
NCT03390816
Management of Malnutrition in Oncogeriatrics
NCT06425315
Association Between Different Parameters of Nutritional Assessment and Clinical Outcomes in Cancer Patients
NCT02901132
Prevalence of Malnutrition in Oncology (PreMiO)
NCT01622036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have signed a written Informed Consent.
Exclusion Criteria
* Patients with neuromuscular disease or hemiplegia.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charite University, Berlin, Germany
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias Pirlich, MD
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gastroenterology, Charité Universitätsmedizin Berlin, Campus Mitte
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Onco400
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.